The foot and mouth disease vaccine is primarily used for preventing foot and mouth disease in livestock animals including cattle, sheep, pigs, goat, and others. Foot and mouth disease is highly contagious viral disease that affects cloven-hoofed animals. The vaccination helps build immunity in animals against foot and mouth disease virus. The vaccines are made from inactivated virus strains that pose no risk of infection but provide protection. The growing demand for milk and meat has fueled large-scale livestock farming worldwide. To prevent potential economic losses due to foot and mouth disease outbreaks in livestock, farmers are increasingly adopting vaccination protocols.
Global foot and mouth disease vaccine market is estimated to be valued at USD 3.15 Bn in 2025 and is expected to reach USD 5.66 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.
Key Takeaways
Key players operating in the Foot And Mouth Disease Vaccine are Bayer AG, Boehringer Ingelheim International GmbH, Merck & Co., Inc. (MSD Animal Health), Indian Immunologicals Ltd., Limber Laboratories Pvt. Ltd., Brilliant Bio Pharma Private Limited, Inova Biotechnologia Saúde Animal Ltda., Biovet Vaxxinova, Veterquímica S.A., MEVAC, Agrovet, Biogénesis Bagó, FGBI - Federal Centre for Animal Health, Vecol S.A., Laboratorios Agrovet S.A., Centro Diagnóstico Veterinario, Razi Vaccine & Serum Research Institute, VETAL Animal Health Veterinary Pharmaceuticals.
The Foot And Mouth Disease Vaccine Market Demand is growing for animal protein and increasing global population has boosted livestock farming activities. This has augmented the need for preventive measures like vaccination against infectious diseases affecting livestock.
Various regions and countries are harnessing vaccination programs to eradicate the foot and mouth disease and facilitate livestock trade. International organizations support vaccination campaigns in developing regions to boost their livestock farming sectors.
Market Key Trends
The adoption of polyvalent vaccines is gaining momentum in the foot and mouth disease vaccine market. Polyvalent vaccines provide protection against multiple strains of the foot and mouth disease virus. This helps prevent potential outbreaks even if the circulating strains differ slightly from the vaccine strains. Their use simplifies vaccination protocols and provides broad protection. Polyvalent vaccines have increased the efficacy of control and eradication programs globally.
Porter's Analysis
Threat of new entrants: The manufacturing process of vaccine requires extensive R&D and stringent regulatory approvals which acts as entry barriers.
Bargaining power of buyers: Presence of many established players increase competition and provide buyers with greater choice and price sensitivity.
Bargaining power of suppliers: Advanced technologies and intellectual properties related to vaccine production provide strong bargaining power to suppliers.
Threat of new substitutes: No major substitute available currently as vaccination remains most effective way to prevent Foot and Mouth Disease outbreak.
Competitive rivalry: High as major players continuously invest in R&D to develop new vaccines and gain market share through strategic collaborations and regional expansion.
The geographical region accounting for the largest share of the global foot and mouth disease vaccine market in terms of value is North America owing to high demand for disease prevention among livestock. Asia Pacific region is expected to witness fastest growth during the forecast period supported by increasing meat consumption, growing animal husbandry industry, and rising awareness among farmers regarding regular vaccination.
Get This Report in Japanese Language - 口蹄疫ワクチン市場
Get This Report in Korean Language - 발굽과 입병 백신 시장
About Author:
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.
(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)
